This product has been shown effective for the vaccination of healthy horses 6 months of age or older against eastern and western encephalomyelitis viruses, equine influenza virus, equine herpesvirus type 1, equine herpesvirus type 4, tetanus and West Nile virus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for eastern and western encephalomyelitis viruses, EHV-1, EHV-4, tetanus and West Nile virus has not been established. This product has been shown to be effective against virus shedding of EIV, EHV-1 and EHV-4 and encephalitis and viremia caused by West Nile virus.
Compositions |
: |
Epinephrine |
Container Type |
: |
Syringe |
Net Content |
: |
1 mL |
- Multiple antigen combination reduces need for several injections
- Formulated to minimize reactions and maximize protection
- West nile virus is the leading cause of arbovirus encephalitis in horses and humans in the United States
- Tetanus, WNV, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
- Provides 6 months of protection against EIV
- A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses, equine herpesvirus types 1 and 4, West Nile virus‐flavivirus chimera and tetanus toxoid
-
Catalog
/ASSETS/DOCUMENTS/ITEMS/EN/https://assets.unilogcorp.com/187/ITEM/DOC/Merck_Animal_Health_103202800_Catalog.pdf
-
Specification Sheet
/ASSETS/DOCUMENTS/ITEMS/EN/https://assets.unilogcorp.com/187/ITEM/DOC/Merck_Animal_Health_103202799_Specification_Sheet.pdf